PTPN18 and ovarian carcinoma: Both Western blot and IHC results showed significantly lower level of PTPN18 in ovarian cancer tissues harvested from mice administrated with sh-PTPN18#1 than those of controls (P < 0.001) (Figures 4(c), 4(d)).